Since results obtained for CLINICAL variables showed poor ability to predict response to NAT, additional parameters related to tumor uptake (ALLMET) were introduced, but only one variable (Glycolysis Q1) remained significant in the multivariate analysis. Here, BRD2 is linked to neoplasm.